Clinique Interdisciplinaire de Mémoire (CIME) du CHU de Québec, Université Laval, Québec, Québec, Canada,
Clinique Interdisciplinaire de Mémoire (CIME) du CHU de Québec, Université Laval, Québec, Québec, Canada.
Dement Geriatr Cogn Disord. 2020;49(5):518-525. doi: 10.1159/000511210. Epub 2020 Nov 18.
It is well known that some patients with Alz-heimer's disease (AD) have atypical, nonamnestic presentations. While logopenic aphasia and posterior cortical atrophy are well-characterized atypical variants of AD, the behavioral/dysexecutive variant remains a controversial entity, lacking consensus regarding its distinctive clinical and imaging features.
We present a case series of 8 patients with biomarker confirmation of AD (cerebrospinal fluid [CSF] analysis or amyloid positron emission tomography [PET]) and a progressive frontal syndrome, defined as prominent behavioral and/or executive deficits at initial presentation. We characterize the cohort based on clinical features, cognitive performance in 4 domains (memory, visuospatial, executive, and language) as well as behavior on the Dépistage Cognitif de Québec (DCQ), and regional brain metabolism using 18F-fluorodeoxyglucose PET (FDG-PET). We compare these features with 8 age-matched patients diagnosed with the behavioral variant of frontotemporal dementia (bvFTD) and 37 patients with typical amnestic AD.
Patients with the behavioral/dysexecutive variant of AD presented with early-onset (mean age: 59 years old) progressive executive and behavioral problems reminiscent of bvFTD, including disinhibition, loss of social conventions, and hyperorality. Patients scored higher on the Memory Index and lower on the Behavioral Index than patients with amnestic AD on the DCQ, yet they were indistinguishable from patients with bvFTD on each of the cognitive indices. Visual analysis of FDG-PET revealed half of patients with behavioral/dysexecutive AD presented with frontal hypometabolism suggestive of bvFTD and only 3/8 (37.5%) presented significant hypometabolism of the posterior cingulate cortex. Group-level analysis of FDG-PET data revealed that the most hypometabolic regions were the middle temporal, inferior temporal, and angular gyri in behavioral/dysexecutive AD and the inferior frontal gyrus, anterior cingulate cortex, caudate nucleus, and insula in bvFTD.
The behavioral/dysexecutive variant of AD is a rare, atypical young-onset variant of AD defined clinically by early and prominent impairments in executive and behavioral domains. While behavioral/dysexecutive AD is hardly distinguishable from bvFTD using clinical and cognitive features alone, CSF biomarkers and temporoparietal hypometabolism help predict underlying pathology during life.
众所周知,一些阿尔茨海默病(AD)患者表现出非典型的、非记忆障碍的症状。虽然语义性失语症和后部皮质萎缩是 AD 的典型非典型变异,但行为/执行功能障碍变异仍然是一个有争议的实体,其独特的临床和影像学特征尚未达成共识。
我们报告了一组 8 例患者的病例系列,这些患者通过生物标志物(脑脊液 [CSF] 分析或淀粉样蛋白正电子发射断层扫描 [PET])证实患有 AD,并伴有进行性额叶综合征,定义为初始表现时突出的行为和/或执行功能缺陷。我们根据临床特征、4 个领域(记忆、视觉空间、执行和语言)的认知表现以及魁北克认知筛查(DCQ)上的行为,以及使用 18F-氟脱氧葡萄糖 PET(FDG-PET)的区域脑代谢来描述该队列。我们将这些特征与 8 例年龄匹配的行为变异额颞叶痴呆(bvFTD)患者和 37 例典型记忆障碍 AD 患者进行比较。
行为/执行功能障碍型 AD 患者表现为早发性(平均年龄:59 岁)进行性执行和行为问题,类似于 bvFTD,包括抑制障碍、丧失社会习俗和口腔过度。与记忆障碍 AD 患者相比,DCQ 上的患者在记忆指数上得分较高,在行为指数上得分较低,但在认知指数上与 bvFTD 患者无法区分。FDG-PET 的视觉分析显示,一半的行为/执行功能障碍型 AD 患者表现出额叶代谢低下,提示 bvFTD,而只有 8 例中的 3 例(37.5%)出现后扣带回皮层明显代谢低下。FDG-PET 数据的组水平分析显示,行为/执行功能障碍型 AD 中代谢最低的区域是中颞叶、下颞叶和角回,而 bvFTD 中代谢最低的区域是下额叶、前扣带皮层、尾状核和脑岛。
行为/执行功能障碍型 AD 是一种罕见的、非典型的早发性 AD 变异型,临床上定义为执行和行为领域的早期和明显损伤。虽然行为/执行功能障碍型 AD 仅通过临床和认知特征很难与 bvFTD 区分,但 CSF 生物标志物和颞顶叶代谢低下有助于预测生前的潜在病理。